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Abstract
Background: Evidence suggests that both preventive and curative nutrition interventions are needed to tackle
child acute malnutrition (AM) in developing countries. In addition to reducing the incidence of AM, providing
preventive interventions may also help increase attendance (and coverage) of AM screening, a major constraint in
the community-based management of child acute malnutrition (CMAM) model. There is a paucity of evidence-
based strategies to deliver integrated preventive and curative interventions effectively and affordably at scale. The
aim of the Innovative Approaches for the Prevention of Childhood Malnutrition (PROMIS) study is to assess the
feasibility, quality of implementation, effectiveness and cost-effectiveness of an integrated child malnutrition
prevention and treatment intervention package implemented through a community-based platform in Mali and a
facility-based platform in Burkina Faso.
Methods/Design: The PROMIS intervention entails a comprehensive preventive package offered on a monthly
basis to caregivers of children, while children are screened for acute malnutrition (AM). The package consists of
behavior change communication on essential nutrition and hygiene actions, and monthly preventive doses of small
quantity lipid-based nutrient supplements (SQ-LNS) for children aged 6 to 23.9 months. Positive AM cases are
referred to treatment services offered by first-line health services according to the CMAM model.
The PROMIS intervention will be evaluated using a mixed methods approach. The impact study encompasses two
types of study design: i) repeated cross-sectional surveys conducted at baseline and at endline after 24 months of
program implementation and ii) a longitudinal study with a monthly follow-up for 18 months. Primary study impact
measures include the incidence and endpoint prevalence of AM, AM screening coverage and treatment
compliance. A process evaluation will assess the feasibility and quality of implementation of the intervention
guided by country specific program impact pathways (PIPs). Cost-effectiveness analysis will assess the economic
feasibility of the intervention.
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Discussion: The PROMIS study assesses the effectiveness of an innovative model to integrate prevention and
treatment interventions for greater and more sustainable impacts on the incidence and prevalence of AM using a
rigorous, theory-based randomized control trial approach. This type of programmatic research is urgently needed to
help program implementers, policy makers, and investors prioritize, select and scale-up the best program models to
prevent and treat AM and achieve the World Health Assembly goal of reducing childhood wasting to less than 5%
globally by the year 2025.
Trial registration: Clinicaltrials.gov NCT02323815 (registered on December 18, 2014) and NCT02245152
(registered on September 16, 2014)
Keywords: Child malnutrition, Small quantity lipid-based nutrient supplement, Behavior change communication,
Prevention, Research protocol
Background
Globally, an estimated 52 million children suffer from
acute malnutrition (AM) [1]. AM dramatically increases
the risk of death: compared to well-nourished children,
children with moderate acute malnutrition (MAM, i.e.
weight-for-length z-score (WLZ) between -3 and -2 SD)
are 3.4 times more likely to die and this goes up to a
staggering 11.6 times in children with severe acute
malnutrition (SAM, i.e. WLZ < -3 SD). Globally, AM or
wasting is the underlying cause for an estimated 875,000
deaths of children under 5 years of age, representing
about 12.6% of all deaths in this age group [1, 2].
The landscape for effective treatment of child SAM has
changed dramatically in the last 10 years. This is due to the
advent of Ready-to-Use Therapeutic Foods (RUTF) to treat
SAM, a high-energy, lipid-based micronutrient-fortified
supplement that can be easily used in field conditions, and
the adoption of Community-based Management of Acute
Malnutrition (CMAM). Under CMAM, children with SAM
(but without complications) are treated at home with
support from the primary health care facility [3]. Recently,
the CMAM model was expanded to include the am-
bulatory treatment of MAM cases using Ready-to-Use
Supplementary Foods (RUSF) or fortified flour blends
[4]. Although the World Health Organization strongly
recommends the CMAM model [3, 5], its effectiveness
remains suboptimal when scaled up due to a combination
of low coverage of screening and of low participation in
seeking and completing treatment schedule [6]. Novel
strategies that can increase CMAM coverage are therefore
highly warranted.
As is the case for many health issues, preventing child
malnutrition is more effective than treating it [7].
Approaches to prevent both acute and chronic child
malnutrition include interventions to improve child
nutrient intakes and foster optimal health, which in turn
rely on households adopting optimal feeding, health, and
care practices [8]. In many resource-constrained envi-
ronments, however, households lack the means to ensure
a nutritionally adequate diet for infants and young
children. Recently developed specialized products, such
as multiple micronutrient powders (MNPs) and small
quantity lipid-based nutrient supplements (SQ-LNS),
provide an opportunity to combine behavior change
communication (BCC) that promotes adequate nutri-
tion, health and care practices with access to products
that help food-insecure households provide a nutrition-
ally adequate diet to their young children [9, 10]. Differ-
ent program models combining BCC and specialized
products, and aimed at preventing child malnutrition
(usually during the first 1000 days), have been developed
and implemented. These preventive programs, however,
have generally been implemented in parallel, rather than
an integrated manner, with programs aimed at treating
SAM. Evidence on how to integrate preventive services
into treatment-focused programs such as CMAM and
on the effectiveness of this approach is missing.
The aim of the Innovative Approaches for the
Prevention of Childhood Malnutrition (PROMIS)
multi-country study is to assess the feasibility, quality
of implementation, effectiveness and cost-effectiveness
of an integrated child malnutrition program that
combines prevention and treatment interventions. The
dual goal of the program is to increase coverage of
screening for CMAM treatment, while also preventing
new or repeated cases of AM. The intervention is imple-
mented by Hellen Keller International (HKI) through a
community-based platform in Senegal and Mali, and
through a facility-based platform in Burkina Faso. PRO-
MIS integrates a BCC intervention (promoting Essential
Nutrition Actions (ENA) and Essential Health Actions
(EHA)), the provision of SQ-LNS supplements for the
prevention of child malnutrition, and the screening and
referral of child AM cases. In Mali and Burkina Faso
impact evaluations on the program’s effectiveness are
conducted, whereas in Senegal only the feasibility of the
program in peri-urban areas is assessed. The present
paper focuses on the (cost-)effectiveness and process
evaluation protocols for the studies in Mali and Burkina
Faso only.
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Methods
Study area
Mali and Burkina Faso, two landlocked countries situ-
ated in west Africa, are amongst the poorest countries in
the world, ranking 179th and 183th on the Human
Development Index, respectively [11]. Approximately 50
and 44% of Mali’s and Burkina Faso’s population live on
less than US $1.90/day [12].
In Mali the study is conducted in the health districts of
Bla and San situated in the Segou region in eastern Mali.
The Bla health district has 28 Health Centers (HC), while
San has 30 HC. Both health districts have one urban HC;
the other HCs are situated in semi-urban or rural settings.
In 2013, the prevalence of AM (defined in the Demo-
graphic and Health Surveys as WLZ < -2 SD) in children
under five in the Segou region was comparable to the na-
tional average (12.9% vs 12.7%); at 3.5%, the prevalence of
SAM (WLZ < -3 SD), however, was amongst the highest
in Mali [13]. In Burkina Faso, the study is conducted in
the Gourcy health district in the Northern region which
includes 32 rural and one urban HC. In 2010 an esti-
mated 16.5% of all children under five suffered from
AM (WLZ < -2 SD) in this region, a prevalence compar-
able to the national average of 16.0%; the prevalence of
SAM (WLZ < -3) was 7.2%, compared to the national
average of 6.0% [14]. The study areas in both countries
rely on rain-fed agriculture for food production; staple
crops such as millet and sorghum are harvested once a
year from September to December. Both study settings
are malaria endemic areas with peak incidence during
the annual rainy season from June to October [15].
Study participants
In Mali, children between 6 and 23.9 months of age be-
longing to the catchment areas of 48 HCs are the target
beneficiaries of the PROMIS intervention and, as such,
constitute the study population. For logistical and budget-
ary reasons, we reduced the total number of HC clusters
from 58 to 48, omitting the 10 most southern HC catch-
ment areas in the San district. These 10 adjacent HC
catchment areas were omitted because they were less
accessible during the rainy season. In Burkina Faso the
study population consists of children 0 to 17.9 months of
age in the catchment areas of 32 rural HCs.
The PROMIS intervention
The PROMIS intervention provides an integrated pack-
age that consists of two key components: 1) prevention
(through age-stratified BCC targeted to the caregivers of
the beneficiary children and the distribution of prevent-
ive doses of SQ-LNS), and 2) screening for, and referral
of cases of AM. The feasibility and adequacy of several
candidate platforms to deliver the program’s integrated
package were assessed before the intervention started.
The final selection made by HKI was based on their field
experience and a quick feasibility assessment in each
country. A comparison of the delivery platforms and the
nutrition-related activities available in the intervention
and control communities is provided in Table 1.
Mali: community-based platform
In Mali, HKI opted to implement the PROMIS interven-
tion package through community health volunteers
Table 1 Overview of PROMIS Program components supported by HKI in Mali and Burkina Faso
Mali Burkina Faso
Control Intervention Control Intervention
PROMIS main delivery platform:
- Monthly village gathering organized by CHV for children 6–23.9 months of age and their caregivers X X
- Monthly WBC at HC for children 0–23.9 months of age and their caregiver X X
PROMIS main integrated packagea (received through PROMIS delivery platform):
- Screening and referral for AM X X X X
- Nutrition, hygiene and health BCC in a large group X X
- Enhanced BCC on ENA/EHA in a small caregiver groups (organized by child age) X X X
- SQ-LNS distribution and SQ-LNS related BCC X X
Other PROMIS activities (through various delivery platforms):
- Capacity building supporting CMAM X X X X
- Support to quarterly screening and referral campaigns X X
- Radio programs on ENA/EHA topics X X X X
- Community theatre performance on ENA/EHA topics X X
- Village nutrition committeeb X X
aThe main integrated package corresponds to a group of services provided at the same time to the same beneficiaries, some as part of the national policy, others
in addition to the national policy
bIn each village, a village nutrition committee comprising 6 influential community members is set up to support BCC and for follow-up of relevant children
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(CHV, relais in French). These community workers are
present in every village in the study area and have as
main responsibility the screening and referral of AM
children within their neighborhood. HKI trained all
CHV from intervention and control study groups in
ENA/EHA related group BCC and set up a supply chain
of SQ-LNS to every village in the intervention study
area. CHV were asked to organize monthly village
gatherings of caregivers with children between 6 and
23.9 months of age to deliver BCC and child AM screen-
ing sessions in all control and intervention villages
throughout the project. In villages with more than 20
beneficiaries, two sessions (for caregivers of children 6–
11.9 months and 12–23.9 months) are organized. Each
monthly BCC session covers one ENA or EHA topic,
which includes recommendations on breastfeeding,
complementary feeding, nutrition during pregnancy and
lactation, malaria prevention, nutrition during child ill-
ness, hygiene and the use of SQ-LNS. The BCC follows
the Greet, Ask, Listen, Identify, Discuss, Recommend,
Agree, set follow-up Appointment (GALIDRAA) com-
munication approach [16]. At each session, children are
screened for AM using mid-upper arm circumference
(MUAC). Positive cases are referred to SAM or MAM
treatment offered by first-line health services. BCC
attendance, as well as the thematic topic discussed, and
the result of the MUAC screening is recorded on the
participant’s program card.
Conditional on their participation to the monthly
village gathering, caregivers of beneficiary children from
intervention villages receive a monthly supply of SQ-
LNS (Nutriset, Malaunay, France) in 20 g sachets
intended for daily use. The nutrient composition of
these peanut-based multiple micronutrient-fortified
supplements is provided in Table 2. The SQ-LNS serve
two purposes: to improve micronutrient intake and to
provide an incentive to attend the BCC and screening
sessions. The distribution of SQ-LNS follows current
guidelines on its use [17], including the promotion of
continued breastfeeding.
Burkina Faso: health service-based platform
In Burkina Faso, the well-baby consultations (WBC,
consultation du nourrisson sain in French) at the HC are
used as the delivery platform. According to national
policy, children between 1 and 12 months of age are
expected to attend preventive WBCs at the HC on a
monthly basis and then attend it every other month up
to the age of 24 months. For PROMIS, this schedule was
modified to include monthly visits for expanded to all
children from 1 to 23.9 months old. Services delivered
during these preventive visits include growth monitoring,
vaccination, vitamin A supplementation and deworming.
Caregivers also receive BCC as per national policy, which
is delivered by CHW and/or HC staff in large groups often
without a well-established curriculum. Caregivers in the
intervention (but not in the control) clusters, receive
additional BCC in smaller groups of 5 to 10 caregivers
stratified by child age at the HC from either HC staff or
CHW. This BCC follows a predetermined curriculum of
ENA and EHA topics and is based on the GALIDRAA
communication approach. The distribution of a monthly
supply of SQ-LNS in the intervention group is limited to
children 6 to 23.9 months of age; the distribution of the
supplements serves the same dual role as in Mali—provid-
ing additional nutrients and incentive to participate in
BCC and screening. HC staff record systematically anthro-
pometry (weight, length and MUAC), and thus screen for
AM, of all children that attend the WBC. Given the extra
workload created by the PROMIS activities, community
health workers (CHW) of the intervention group receive a
small monetary incentive from HKI to support health staff
in delivering the preventive package.
Table 2 Composition of a daily dose (20 g) of SQ-LNS




Linoleic Acid, g 4.5











Vitamin A, mg 0.4
Vitamin B1, mg 0.3
Vitamin B2, mg 0.4
Niacin. mg 4.0
Pantothenic acid, mg 1.8
Vitamin B6, mg 0.3
Folic acid, μg 80
Vitamin B12, μg 0.5
Vitamin C, mg 30
Vitamin D, μg 5
Vitamin E, mg 6.0
Vitamin K, μg 30
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In both countries, HKI supports a number of other
activities related to screening for and the prevention of
AM. These activities take place outside the PROMIS
delivery platforms, do not integrate screening and pre-
vention, and are available to both treatment and inter-
vention communities (Table 1). In both Mali and
Burkina Faso, HKI supports the development of radio
shows that sensitize the community on ENA/EHA
topics. In Burkina Faso, HKI initiated theater plays on
ENA/EHA topics; it supported the creation of village
nutrition committees composed of 6 influential commu-
nity members (2 respected elderly women, 2 CHW and
2 representatives of village authorities) to provide BCC
on ENA/EHA, to screen children for AM and to pro-
mote adequate ENA/EHA practices; finally, it supports




In both countries a two-arm cluster-randomized, non-
masked, community-based, trial is used to estimate the
effectiveness of the PROMIS intervention. The unit of
randomization is the catchment area of the HC. PRO-
MIS has the potential to reduce the prevalence of AM
through two distinct pathways: 1) the preventive compo-
nent (i.e. BCC and the consumption of SQ-LNS), which
is expected to lower the incidence and consequently the
prevalence of AM; and 2) the screening for AM compo-
nent, which is expected to increase the number of cases
identified, referred and treated. If early screening, refer-
ral and treatment are effective, it is expected that the it
will shorten the duration of the episodes of AM and
consequently also contribute to lowering its prevalence.
To assess the importance of each pathway, the study
combines a repeated cross-sectional and a longitudinal
study design.
The repeated cross-sectional study design uses data
collected at baseline and after 24 months of program
implementation among a representative sample of chil-
dren 0–17.9 months and 6–23.9 months of age in
Burkina Faso and Mali, respectively. The cross-sectional
study design allows us to assess the impact of the pro-
gram on the prevalence of MAM and SAM in the full
age range targeted by the program. In addition, the
cross-sectional data will be used to assess the impact of
the program on stunting, on the coverage of screening
for AM, and on maternal knowledge and practices
related to the BCC topics emphasized in the study (ma-
ternal and child health, nutrition and IYCF, and water,
sanitation and hygiene).
The longitudinal study recruited individual children at
0–1.4 months (Burkina Faso) and 6–6.9 months of age
(Mali). In each country, cohort children are followed
monthly for 18 months to assess the impact of the
preventive component of the program on the incidence
of AM. Additionally, the longitudinal design is used to
assess the impact of the program on child morbidity and
to document changes in caregivers’ ENA/EHY knowledge
and practices.
Study outcomes
Primary study outcomes for the cross-sectional study
design in Mali and Burkina Faso are:
i) the prevalence of AM defined by aWLZ < -2 or a
MUAC < 125 mm (only in children older than
6 months) or the presence of bilateral pitting edema;
ii) AM screening coverage defined as the number of
children screened in the month preceding the survey
(as reported by the caregiver) over the total number
of eligible study children;
iii)AM treatment compliance defined as the number of
AM children under appropriate treatment at the
time of the survey over the total number of AM
cases identified in the study sample.
Secondary study outcomes for the cross-sectional study
include anthropometric outcomes mean WLZ, MUAC and
Length-for-Age Z-score(LAZ), the prevalence of child
stunting (LAZ < -2 SD) and severe stunting (LAZ < -3 SD),
the prevalence of SAM (defined by WLZ < -3 SD, a
MUAC < 115 mm (children older than 6 months), or bilat-
eral pitting edema)); mean hemoglobin (Hb) concentration,
child anemia (Hb < 11 g/dL) and severe anemia (Hb <7 g/
dL); caregivers’ ENA and EHA and IYCF knowledge and
practices.
For the longitudinal study, primary outcomes in both
countries are
i) the incidence of AM (same definition of AM as
above);
ii) monthly AM screening coverage (the number of
children screened each month over the total number
of eligible study children);
iii)AM treatment compliance (the number of AM
children adhering to weekly or bi-weekly treatment
until discharged over the total number of AM
children that were scheduled for treatment).
Secondary outcomes include the relapse rate after
treatment of MAM and SAM (number of MAM or
SAM cases detected after being successfully discharged
from MAM or SAM treatment), ponderal and linear
growth (monthly WLZ and LAZ increment, respect-
ively), incidence of stunting (LAZ < -2 SD), MUAC gain
(MUAC increment per month), longitudinal prevalence
(ie. number of days of illness divided by the total
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number of days of observation for each child) of child
morbidity (acute respiratory infections, fever, diarrhea,
vomiting, and malaria), patterns of child morbidity
prevalence over time, caregiver’s knowledge and prac-
tices related to IYCF and ENA/EHA.
Sample size
We used Hayes and Bennet’s formulas to calculate the
necessary sample sizes for the repeated cross-sectional
and the longitudinal study [18]. For the repeated cross-
sectional study design, we assumed a coefficient of inter-
cluster (i.e. between HC) variation k of 0.25, a non-
response rate of 15%, a type I error of 5% and a statis-
tical power of 80%. In Mali we found that with an aver-
age cluster (i.e. HC catchment area) size of 48 children,
48 clusters (i.e. an overall sample size of 2304 children)
will allow us to detect a decrease in the prevalence of
AM of 5.3 percentage points assuming a baseline preva-
lence of 18.0%. This sample size allows us to detect a
difference in screening coverage and treatment compli-
ance of 6.7 percentage points between study groups as-
suming baseline values of 25% for both outcomes. In
Burkina Faso, 32 rural clusters with an average cluster
size of 72 children (2304 children total), will allow us to
detect a decrease in the prevalence of AM of 5.4 per-
centage points assuming a baseline prevalence of 16.0%.
This sample size allows us to detect a difference in
screening coverage and treatment compliance of 7.5 per-
centage points between study groups assuming baseline
values of 25% for both outcomes.
The longitudinal study is conducted in the same
villages as the cross-sectional survey to maximize com-
parability. We assumed a coefficient of inter-cluster vari-
ation k of 0.2, a dropout rate of 20%, a type I error of 5%
and a statistical power of 80%. In Mali, with 24 children
in each of the 48 clusters (1152 children total) we can
detect a 23.5% reduction in the incidence of AM, assum-
ing a baseline incidence of 0.61 case per child-year. For
Burkina Faso, 66 children in each of the 32 available
clusters (total sample size of 2112 children) will allow us
to detect a 23.5% change in the incidence of AM assum-
ing a baseline incidence of 0.52 cases per child-year.
Randomization, sampling and study planning
In Mali, we applied stratified random allocation of the
HC catchment areas to control and intervention study
groups. HCs are governed by their own community
health association and operate autonomously. They are
thus expected to be quite heterogeneous in terms of
organization and performance [19]. Stratifying clusters
prior to randomization ensured a more balanced distri-
bution of cluster-level covariates between study arms.
We first stratified the HCs by hierarchical clustering
using a set of criteria that are detailed in Table 3. Based
on the visual inspection of the obtained cluster dendro-
gram obtained from hierarchical clustering with
complete linkage, we subdivided the clusters into 3
strata for the Bla district and 2 strata for the San district.
Random allocation to control or intervention groups
was conducted within each stratum during a community
ceremony in Bla and San in the presence of local health
authorities. Forty-eight identical pieces of paper with ei-
ther ‘control’ (n = 24) or ‘intervention’ (n = 24) written
on them were mixed in a bag by the project coordinator
of HKI. Each HC director drew one piece of paper thus
allocating his HC catchment area to the control or inter-
vention study group.
In Burkina Faso, simple (i.e. non-stratified) random
allocation was used. As in Mali, randomization took
place at a community event in Gourcy with local health
authorities. Thirty-two identical pieces of paper with
either ‘control’ (n = 16) or ‘intervention’ (n = 16) written
on them were mixed in a bag for randomization of the
32 rural HC. The allocation of the urban HC was con-
ducted separately by drawing a piece of paper from a
bag containing 2 pieces of paper (1 ‘control’ and 1 ‘inter-
vention’). The primary impact analysis in Burkina Faso
will be limited to the 32 rural HC catchment areas since
the services offered and the population served in the
urban HC are not comparable to those at the rural HCs.
In each country, a census to identify infants and
pregnant women was organized prior to the start of
the cross-sectional surveys and prior to the beginning
of the longitudinal study. In Mali, we excluded vil-
lages and small settlements with a population of less
than 300 to lower the logistical cost. In Burkina Faso,
when the HC catchment area included more than 3
villages, we randomly selected 3 villages (using prob-
ability proportional to population size sampling) and
then randomly selected an equal number of house-
holds with an eligible child using Stata. Since age is
an important predictor of AM and nutrition and
Table 3 Criteria used to stratify HC catchment areas in Mali
Criteria
- Type of staff working in HC
- Accessibility during rainy season
- Type of the catchment area (urban/semi-urban/rural)
- Number of villages covered
- Number of villages with community health workers (CHW)
- Vaccination coverage
- Total number of children 6-23.9 months
- Proportion MAM admissions/total population
- Proportion SAM admissions/total population
- Distance between villages and HC
- Distance between HC and District hospital
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health related practices, we stratified children in three
equal age groups (Mali: 6–11 m; 12–17 m; 18–23 m
and Burkina Faso: 0–5 m; 6–11 m; 12–17 m) and
drew a random sample from each age group for the
cross-sectional study.
Inclusion criteria for the cross-sectional study were: i)
a child 6–23.9 months (Mali) or 0–17.9 months of age
(Burkina Faso); ii) child’s main caregiver living the study
area since the child’s delivery; iii) child without congenital
malformations that hinder the measurement of anthro-
pometry. The inclusion criteria for the longitudinal study
were: i) a child 6–6.9 months (Mali) or 0–1.4 months of
age (Burkina Faso); ii) child not being in a state of AM; iii)
child’s main caregiver living the study area since the child’s
delivery; iv) child without congenital malformations that
hinder the measurement of anthropometry.
The baseline cross-sectional surveys were conducted
between November-December 2014 and February-March
2015 in Burkina Faso and Mali, respectively. Endline
surveys are organized 24 months later during the same
calendar months in both countries. The longitudinal study
recruited eligible children between March and August
2015 in Burkina Faso and between July and September
2015 in Mali. Cohort children are followed up monthly
for 18 months. The last follow-up measurements for the
longitudinal study are foreseen for February 2017 in
Burkina Faso and April 2017 in Mali.
Questionnaires
Data are collected at the HC, community, household,
and individual level using questionnaires. HC staff ques-
tionnaire (administered as part of the cross-sectional
survey) assesses, among others, the organization of pre-
ventive and CMAM consultations, staff occupancy, HC
facilities, stock turnover of medicines and therapeutic
foods. The community health worker questionnaire (also
administered as part of the cross-sectional survey) fo-
cuses on the screening, referral and follow-up activities
for MAM and SAM cases in the community. Both the
health staff and CHW questionnaires further assess
ENA, EHA and CMAM knowledge as well as job satis-
faction, supervision and training received. Household
questionnaires were developed for the cross-sectional
and longitudinal studies. Figure 1 gives an overview of
Fig. 1 Household questionnaire items and chronogram of measurements for PROMIS Mali (light blue) and Burkina Faso (orange); abaseline and
endline from the repeated cross-sectional surveys
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the questionnaire themes and the timing of administra-
tion. All survey data are collected through a Computer-
assisted personal interviewing format (CAPI) designed
using Surveybe version 4 and 5 software (Surveybe, UK).
Measurement instruments
The child’s weight is measured to the nearest 100 g using
an electronic scale (SECA 876, Germany). Length is mea-
sured to the nearest 1 mm using a length board (Weigh
and Measure LCC, USA). Mid-upper arm circumference
measurements are obtained using a non-stretchable tape
with 0.1 cm precision (SECA 201, Germany). All measure-
ments are taken in duplicate by an anthropometrist and
an assistant. Maternal weight and height are recorded
using scales (SECA 877) and stadiometers (Weigh and
Measure LCC, USA) respectively. WLZ and LAZ
scores will be calculated using the 2006 World Health
Organization growth reference [20]. All anthropome-
trists were standardized before the fieldwork started
against measurements of a lead anthropometrist and
are re-standardized every 2 months throughout the
longitudinal study [21]. Children that are diagnosed
with AM are referred to the nearest health center
where treatment is offered free of charge.
A 3-day recall period is used for infant morbidity
(acute respiratory infections, diarrhea, fever and mal-
aria). This recall period leads to more accurate estimates
at the expense of a small to moderate loss of statistical
power as compared to a 7-day recall period, especially if
morbidity signs are common, the number of measure-
ments per individual exceeds 10 or 12, and in cluster-
randomized trials [22]. A diarrheal episode is defined by
at least 3 liquid or semi-liquid stools in the last 24 h.
Fever is assessed in two ways. First, it is measured using
a standard thermometer. If no fever is recorded, fever
episodes are assessed through 24 h recall. The presence
of acute respiratory infection (ARI) is defined as pres-
ence of specific ARI-related symptoms being cough,
difficulty breathing, grunting, rapid breathing, using a 3-
day recall. Malaria is diagnosed using a fingerpick rapid
diagnostic test in cases where the child’s axillary
temperature is over 37.5 °C or the mother reports fever
in the last 24 h. Child Hb concentration in capillary
blood is measured by spectrophotometry using a port-
able HemoCue device (HemoCue Ltd, Dronfield, United
Kingdom). Children that are diagnosed with severe
anemia or malaria are referred to the nearest HC for
treatment. For all such cases the project covers the
charges related to consultation and treatment.
Data management and analysis
The repeated cross-sectional study design will be used
to estimate program impact after 2 years of program
implementation. Linear and linear probability mixed-
effect regression models will be used for continuous and
binary outcomes respectively. Although the randomization
is expected to minimize average differences at baseline
between groups, we will adjust regression models for base-
line values of the outcome of interest and covariates that
should not have changed as a consequence of the inter-
vention to improve the precision of the estimates. Regres-
sion models will further be adjusted for clustering at HC
catchment area level. Explorative analysis will assess effect
modification by HC and CHW characteristics by testing
interaction terms and if statistically significant at 10% level
considered for sub-group analysis.
The monthly measurements of child weight, MUAC
and WLZ increments, and linear growth (length and
LAZ increments) in the longitudinal study will be mod-
eled using linear mixed-effects models which will in-
clude an interaction term between follow-up time and
intervention allocation to assess the intervention’s
impact on these outcomes over time. All longitudinal
analysis models will further be adjusted for child sex,
child age, primiparity, the baseline value of the outcome
of interest, covariates that should not have changed
as a consequence of the intervention, stratum of HC
catchment areas (in Mali). Interactions between inter-
vention and baseline covariates will be inspected and
if statistically significant at 10% level considered for
sub-group analysis.
For the analysis of AM incidence and the longitudinal
prevalence of morbidity, we will use mixed-effects
Poisson regression models with robust estimation of
standard errors. The mixed-effects models will be
adjusted for clustering by HC catchment area and indi-
vidual to estimate the correct standard errors. Data will
be analyzed on intention-to-treat basis.
We plan a causal mediation analysis using the longitu-
dinal data to identify the pathways of impact on the
primary study outcomes. Multiple imputation of missing
data will be conducted to assess the robustness of the
findings.
Data management, data cleaning and statistical ana-
lyses will be done using Stata 14.1 (Statacorp, USA). The
statistical significance will be set at 5%. All statistical
tests will be two-sided.
Cost and cost-effectiveness
Costs are estimated using a combination of ingredients
based and Activity-Based Costing methods (ABC-I). The
ABC-I method defines all the activities associated with
program implementation and assesses the cost of all of
the ingredients (i.e. inputs) used to achieve each activity.
Costs are measured as the economic costs (i.e. taking a
societal perspective) and not just as the accounting cost.
The costs of volunteer labor, in-kind donations, and
household time, for instance, are included in the total
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cost. The study thus includes all relevant costs incurred
by institutions and communities [23–25], but will also
assess the opportunity costs made by mothers to partici-
pate in the program. Data on costs and the allocation of
resources across activities were collected through
reviewing the programs’ accounting records and docu-
mentation, and through key informant interviews and
focus group discussions with relevant program imple-
mentation staff.
Analysis will focus on the total program costs, the
incremental costs of the additional activities in the inter-
vention area, and will disaggregate by costs for prevent-
ive versus treatment interventions. Cost-effectiveness
ratios will be calculated using costs and the impact on
the primary outcomes of the intervention. Incremental
cost-effectiveness ratios will be calculated by dividing
the additional costs in the intervention area by the add-
itional number of cases of AM averted and the change
in the prevalence of AM at endpoint in the intervention
area (as compared to the control area). This ratio repre-
sents the additional cost to prevent one additional case
of AM or to reduce AM prevalence by one percentage
point. Comparison with other similar published work
will be considered where appropriate.
Process evaluation
The overall objective of the process evaluation is to
assess the feasibility, quality of implementation and ser-
vice delivery, and to identify operational and utilization
constraints. The process evaluation examines the pri-
mary inputs, processes, outputs, and outcomes along the
program impact pathway in order to determine the
“how” and “why” of program impact. The specific objec-
tives of the process evaluation, along with the corre-
sponding study methods and the study population or
program delivery points studied in each country are
detailed in Table 4.
Since the design of a rigorous process evaluation re-
quires a solid understanding of the program impact
pathway (PIP), the first step was to develop a PIP in both
countries [26]. We reviewed program documents and
consulted with program designers, implementers, and
managers to be sure the intended program implementa-
tion and outcomes were appropriately represented. The
PIP documents the institutions implicated in the pro-
gram; the actors involved in the program; the flow of
program inputs through those institutions and actors;
the sequencing of events; and the envisioned effects of
the program.
A combination of random and purposive sampling
techniques was used for the process evaluation. Three
focused ethnographic data collection methods were
used: semi-structured continuous observations of pro-
gram activities, semi-structured individual qualitative
interviews with implementation staff and beneficiary
mothers, and group free listing with beneficiary mothers.
Semi-structured continuous observation is a technique
where the researcher observes activities of a participant
Table 4 Process evaluation objectives, research methods, and program delivery point or study population by program level
Program Level Objectives Research Method Program Delivery Point or Study Population
Program Implementation • Describe the actual implementation






Mali: Monthly village gathering/
point of distribution of SQ-LNS
• Understand key stakeholders’ (frontline
health agents) perceptions of specific
aspects of the program
• Understand how the program is integrated
into the existing health system
• Describe how the program contributes to
the implementation of the national protocol
• Describe how the program adds to the
frontline health agents’ workload
Individual semi-structured
qualitative interviews
Burkina Faso: Health staff; community
health workers involved in the
implementation of the program
at the level of the HC
Mali: CHVs directly involved in the
implementation of the program
Household & Individual
Beneficiary Utilization
• Understand mothers’ perception of the
program, perceived incentive structure
and individual costs
of receiving the program
• Understand mothers’ barriers and facilitators
to participate in the program
• Understand the perception of mothers of
the quality of services at the CSPS/CSCOM




Burkina Faso & Mali: Mothers of children
who are eligible for the program
• Describe individual use of SQ-LNS
• Identify salient program messages
for mothers
Group free listing Burkina Faso: Mothers of children who
have attended WBC
Mali: Mothers of children who have
attended monthly group BCC/SQ-LNS
distribution
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or a set of participants directly without engaging in
those activities or interrupting to ask questions. Individ-
ual semi-structured qualitative interviews consist of
questions and probes that are open-ended, but are
guided by a set of topics and questions to be discussed
between the interviewer and one respondent. These
semi-structured interviews are intended to illuminate
the “why” and “how” and provide depth of understand-
ing of a particular issue. Free listing is used to generate
data that describes how items within a discrete domain
(with list-able content) are categorized within a particu-
lar group of people; the order in which the item falls in
the list, and the number of times an item appears
across multiple lists represents the “saliency” of the
item [27–29]. In analyzing the frequency of messages
that beneficiary mothers report receiving as part of
the program, we will be able to determine which pro-
gram messages are most salient for these mothers.
The breadth of a particular domain can also be illus-
trated with free listing, generating a wide range of
items that constitute a domain for that specific group
[27–29]. In this study, we use free listing to describe
the variety of ways in which SQ-LNS was fed to the
child (or by other people).
Data are recorded by hand (semi-structured continu-
ous observation, free listing) and by digital recorders
(semi-structured interview, free listing). A narrative
summary is written by the enumerator conducting the
semi-structured continuous observation immediately
following data collection. Digitally recorded semi-
structured interview data are transcribed and translated
simultaneously from the local language into French by
bilingual transcribers. For the free listing, the digital
recording served to check the data collected by hand.
Semi-structured continuous observation data are
coded using grounded theory (i.e., the researcher codes
data without a pre-defined code list and mark themes as
they emerge in the data). Semi-structured interview data
are coded using list of codes developed a priori based on
the research questions and themes of interest. All coding
utilizes NVivo v.11 software. Coded output will be sum-
marized by themes that correspond to the specific
process evaluation research objectives. Free listing data
are coded by category of interest and analyzed using
basic descriptive statistics.
Discussion
Child AM continues to be a major global health problem
[2]. The answer to this challenge lays in the effective
implementation of the CMAM model ensuring sufficient
screening and treatment coverage of AM cases. Inte-
grated programs that work both on the prevention and
curative side of undernutrition hold the potential to re-
duce the prevalence of AM by reducing its incidence
and enhancing its treatment effectiveness. Evidence on
how to successfully integrate preventive services into
treatment programs for AM however is missing. As a
consequence, nothing is known about the effectiveness
of this approach.
The Innovative Approaches for the Prevention of
Childhood Malnutrition (PROMIS) seeks to fill these
knowledge gaps and uses a rigorous, theory-based ran-
domized control trial approach to assess the effective-
ness of an innovative model to integrate prevention and
treatment interventions for greater and more sustainable
impacts on the incidence and prevalence of AM. The
study’s cross-sectional and longitudinal components will
allow us to disentangle the program’s effect on the inci-
dence and prevalence of child AM. The evaluation also
includes a strong process evaluation component that will
help document implementation successes and chal-
lenges, including on delivery and quality of the programs
as well as on utilization by targeted beneficiaries. The
costing and cost-effectiveness components will provide
rich data on another neglected area—information on
how much it would cost to accelerate progress in redu-
cing AM. This type of evidence is urgently needed to
help program implementers, policy makers, and inves-
tors prioritize, select and scale-up the best program
models to prevent AM and achieve the World Health
Assembly goal of reducing childhood wasting to less
than 5% globally by the year 2025.
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